a:head bio AG
Facts
- Founded
- 2019
- Staff
- 9
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
Profile
a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
R&D:a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement.
Similar companies in RDM biotech/pharma
Oxford Antibiotic Group GmbH
- Organization type
- RDM biotech/pharma
- Region
- Lower Austria
- Cluster
- ecoplus
- Focus
- human health
NBS-C BioScience
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health
Green River Polymers Forschungs- und Entwicklungs GmbH
- Organization type
- RDM biotech/pharma
- Region
- Tyrol
- Focus
- industrial processing
Cyathus Exquirere PharmaforschungsGmbH
- Organization type
- RDM biotech/pharma
- Region
- Lower Austria
- Cluster
- LISAvienna
- Focus
- human health
Contact
Dr.-Bohr-Gasse 7, VBC6
1030 Wien
Vienna
Contact: Oliver Szolar (CEO)
Email: office@aheadbio.com
Website